Investigation on Mouse Model of Type 2 Diabetes Mellitus Combined with Alzheimer's Disease

doi:10.3969/j.issn.1674-5817.2018.01.005

Abstract

Abstract: Objective To construct a mouse model of type 2 diabetes mellitus (T2D) combined with Alzheimer's disease (AD).Methods The male (APP/PS1^+/+/db/db^+/+) mice and female (APP/PS1^-/-/db/db^+/-) mice were hybridized.The male and female offspring with genotype (APP/PS1^+/-/db/db^+/-) were mated,and produced the offspring with genotype (APP/PS1^+/+/db/db^-/-) as the model group (group M);with genotype (APP/PS1^-/-/db/db^+/+) and (APP/PS1^-/-/db/db^+/-) as the control group (group C).Thirty mice randomly selected from 2 groups were divided into 3 subgroups with the age of 4,14 and 25 weeks old respectively.The metabolic indexes,such as body weight,fasting blood glucose,postprandial blood glucose,blood sugar insulin content and insulin resistance index,of mice in different groups were detected.The learning and memory ability of mice were detected through the water maze test.The anatomical feature of brain tissue (brain weight and cortical and hippocampal area) were detected via cresyl violet staining,and the microglia,astrocytes,and the content and distribution of A protein and senile plaques (SP) in cortex and hippocampus were detected by immunohistochemistry staining.Results Animals in M group,starting from 4 weeks of age,body weight index was significantly increased compared with C group on blood glucose,insulin content and insulin resistance (P<0.01).While the brain weight,search platform latency,the original platform quadrant time ratio were significantly decreased (P<0.01).At 14 weeks of age,area of cerebral cortex and hippocampus decreased significantly (P<0.01),tau protein phosphorylation level was significantly increased (P<0.01).At 25 weeks of age,cortex and hippocampus A beta deposition,and the formation of SP at the same time,microglia and astrocytes increased significantly (P<0.01).Conclusion The established mouse model of T2D combined with AD,which provided a platform for study of the relationship between the two diseases and development of therapeutic drugs.

Key words: Type 2 diabetes mellitus (T2D), Alzheimer's disease (AD), Insulin resistance, Senile plaque (SP), Water maze test

CLC Number:

Q95-33

CHEN Zhi-ling, WU Hua, SONG Xin-lei. Investigation on Mouse Model of Type 2 Diabetes Mellitus Combined with Alzheimer's Disease[J]. Laboratory Animal and Comparative Medicine, 2018, 38(1): 29-35.

References

[1] 廖涌.中国糖尿病的流行病学现状及展望[J].重庆医科大学学报,2015(7):1042-1045.
[2] Alzheimer’s Association.2014 Alzheimer’s disease facts and figures[J].Alzheimers Dement,2014,10(2):e47-e92.
[3] de la Monte SM.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease[J].Drugs,2012,72(1):49-66.
[4] Yarchoan M,Arnold SE.Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.[J].Diabetes,2014,63(7):2253.
[5] Niedowicz DM,Reeves VL,Platt TL,et al.Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia[J].Acta Neuropathol Commun,2014,2(1):64.
[6] Truett GE,Heeger P,Mynatt RL,et al.Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)[J].Biotechniques,2000,29(1):52,54.
[7] 赵璐,何婷,丁文欢,等.考马斯亮兰法(Bradford法)测定驼乳中蛋白质的含量[J].应用化工,2016,45(12):2366-2372.
[8] U.S.Department of Health and Human Services,Food and Drug Administration,Center for Drug Evaluation and Research (CDER).Guidance for industry-diabetes mellitus:developing drugs and therapeutic biologics for treatment and prevention[EB/OL].2008.http://www.fda.gov/downloads/Drugs/Guidances/ucm071624.pdf.
[9] Calcutt NA,Cooper ME,Kern TS,et al.Therapies forhyperglycaemia-induced diabetic complications:from animalmodels to clinical trials[J].Nat Rev Drug Discov,2009,8:417-429.
[10] 成龙,申竹芳,孙桂波,等.糖尿病动物模型研究进展及在中药研究中的应用[J].药学学报,2015(8):951-958.
[11] 金范莹,张宝荣.老年痴呆的遗传机制研究进展[J].生命科学,2014,26(1):15-26.
[12] Guo C,Zhang S,Li J Y,et al.Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model[J].Sci Rep,2016,6:29396.
[13] Knight EM,Ruiz HH,Kim SH,et al.Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1[J].Acta Neuropathol Commun,2016,4(1):16.